Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sotrovimab for Treatment of COVID-19 in Solid Organ Transplant Recipients
Abhay Dhand, Kenji Okumura, Kevin Wolfe, et al.
Transplantation (2022) Vol. 106, Iss. 7, pp. e336-e337
Open Access | Times Cited: 19

Showing 19 citing articles:

COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era
Jessica Hedvat, Nicholas W. Lange, David M. Salerno, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 11, pp. 2682-2688
Open Access | Times Cited: 48
COVID-19 among Kidney Transplant Recipients: Evaluating Risk Factors During the Initial Phase of the Pandemic
Alexandra Nowak, Aurora Caldinelli, Mårten Segelmark, et al.
Clinical Kidney Journal (2025) Vol. 18, Iss. 3
Open Access
Experience with sotrovimab treatment of SARS‐CoV‐2‐infected patients in Denmark
Line Dahlerup Rasmussen, Anne‐Mette Lebech, Anne Øvrehus, et al.
British Journal of Clinical Pharmacology (2022) Vol. 89, Iss. 6, pp. 1820-1833
Open Access | Times Cited: 11
Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients
Florentino Villanego, Auxiliadora Mazuecos, Beatriz Rodríguez Cubillo, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 10, pp. 1847-1855
Open Access | Times Cited: 10
Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19
Zeyuan Zheng, Huimin Sun, Xiao Hu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
COVID-19 in kidney transplantation-implications for immunosuppression and vaccination
Lavanya Kodali, Pooja Budhiraja, Juan Gea‐Banacloche
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Sotrovimab therapy in solid organ transplant recipients with mild to moderate COVID-19: a systematic review and meta-analysis
Negin Farhadian, Maryam Farhadian, Mohammad Hossein Zamanian, et al.
Immunopharmacology and Immunotoxicology (2022) Vol. 45, Iss. 4, pp. 402-408
Closed Access | Times Cited: 8
The COVID-19 Pandemic and Adult Cardiac Transplantation: Impact, Interventions, and Implications
Sharon Chih, Brian Clarke, Martin Albert, et al.
Canadian Journal of Cardiology (2023) Vol. 39, Iss. 6, pp. 853-864
Open Access | Times Cited: 4
Evaluation of outpatient treatment for non-hospitalised patients with COVID-19: The experience of a regional centre in the UK
Amanda Goodwin, Jonathan Thompson, Ian P. Hall
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0281915-e0281915
Open Access | Times Cited: 2
Sotrovimab in the treatment of coronavirus disease-2019 (COVID-19): a systematic review and meta-analysis of randomized clinical trials
Ana Flávia Amorim, Joselin Valeska Martinez-Sobalvarro, Larissa Helena Torres, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9573-9589
Closed Access
Clinical practice guideline supported administration of monoclonal antibody therapy for high-risk patients with COVID-19: Experience of a quaternary care centre
K. Hammond, François Bourdeau, Marina Klein, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada (2024)
Closed Access
Coronavirus Disease 2019 (COVID-19) in Heart Transplant Recipients and Anti-SARS-CoV-2 Monoclonal Antibodies: Experience, Lessons Learnt, and Future Challenges
Rohan Kapur, Kenji Okumura, Suguru Ohira, et al.
Cardiology in Review (2024)
Closed Access
Sotrovimab: una opción terapéutica en trasplante pulmonar
Rosa Gutiérrez-Larraya-Sánchez-Andrade, Marta Erro-Iribarren, Silvia Aguado-IbánÓez, et al.
Revista de Patología Respiratoria (2024) Vol. 27, Iss. 1
Open Access
Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies
Francisco Javier Candel, Miguel Salavert, David Lorite Mingot, et al.
Revista Española de Quimioterapia (2023) Vol. 36, Iss. 4, pp. 380-391
Open Access | Times Cited: 1
Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high‐risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves
Kristen Zeitler, Nicholas Piccicacco, Melissa O’Neal, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 4
Closed Access | Times Cited: 1
Experience in the use of neutralizing monoclonal antibodies in kidney transplant recipients with COVID-19
I. G. Kim, М.А. Лысенко, N.F. Frolova, et al.
Russian Journal of Transplantology and Artificial Organs (2023) Vol. 25, Iss. 1, pp. 7-14
Open Access

J Barberán, López Comité, F. Lerma, et al.
Revista Española de Quimioterapia (2023) Vol. 36, Iss. 4
Open Access
Clinical experience in the treatment of COVID-19 with monoclonal antibodies in solid organ transplant recipients
Elena Múñez, Jorge Calderón‐Parra, Andrea Gutiérrez‐Villanueva, et al.
Revista Española de Quimioterapia (2023) Vol. 36, Iss. Suppl1, pp. 25-28
Open Access
Rapid deterioration of renal function following coronavirus disease 2019 in a renal transplant recipient
Seigo Machiya, Shigeaki Nakazawa, Shota Fukae, et al.
IJU Case Reports (2022) Vol. 6, Iss. 2, pp. 120-123
Open Access
Page 1

Scroll to top